Research overview
What is IGF-1 LR3?
Long R3 IGF-I differs from native IGF-I by an N-terminal extension and an arginine substitution near residue three. These modifications reduce affinity for some IGF-binding proteins. Recombinant Long R3 material is used as a cell-culture reagent, and those laboratory uses do not establish a medicine for independently sourced vials.
What has research examined?
A guinea-pig infusion study compared long R3 IGF-I with other growth factors and measured organ growth and circulating IGF-system components; its authors noted reduced IGF-binding-protein affinity. A newer fetal-sheep experiment did not find the predicted growth benefit in a growth-restricted setting. These results illustrate context-dependent animal effects rather than a reliable human physique or recovery outcome.
Animal growth measures and cell-culture reagents do not establish safety, treatment, or performance effects in humans. The analogue should not be conflated with any approved mecasermin formulation. No amount, schedule, preparation, or use is recommended.
Research references
- Long R3 IGF-I infusion stimulates organ growth but reduces IGF-system concentrations in guinea pigsJournal of Endocrinology; animal study
- IGF-1 LR3 does not promote growth in late-gestation growth-restricted fetal sheepPediatric Research; animal study
Calculation boundary
The calculator performs concentration arithmetic only when a user enters a mass and liquid volume. It does not verify identity, formulation, purity, sterility, stability, compatibility, biological-unit equivalence, or whether reconstitution applies to a particular product. Do not convert IU or other biological units to mg without an authoritative, exact-product relationship.